BACKGROUND: Elevated serum uric acid has been associated with cognitive dysfunction and vascular cognitive impairment in the elderly. Serum uric acid is also commonly elevated in chronic kidney disease (CKD), but its relationship with cognitive function in these patients has not been addressed. METHODS: Subjects with CKD (defined as eGFR <60/ml/min/1.73 m(2)) were evaluated for cognitive dysfunction using the validated Standardized Mini-Mental State Examination (SMMSE). Individuals with dementia, depression or other psychiatric disorders were excluded, as were subjects on uric acid-lowering therapy or with serious illnesses such as severe anemia or active or ongoing cardiovascular or cerebrovascular disease. RESULTS: 247 subjects were enrolled. SMMSE scores showed stepwise deterioration with increasing quartile of serum uric acid (26.4; 26.1; 25.5; 25.3, score range 20-30, p = 0.019). Post-hoc analysis demonstrated that there was no linear trend and only groups 1 and 4 were different with respect to SMMSE scores (p = 0.025). Stepwise multivariate linear regression revealed that age, educational status, presence of cerebrovascular disease, and serum uric acid were independently related to SMMSE scores. CONCLUSION: Serum uric acid levels are independently and inversely associated with mild cognitive dysfunction in subjects with CKD.
BACKGROUND: Elevated serum uric acid has been associated with cognitive dysfunction and vascular cognitive impairment in the elderly. Serum uric acid is also commonly elevated in chronic kidney disease (CKD), but its relationship with cognitive function in these patients has not been addressed. METHODS: Subjects with CKD (defined as eGFR <60/ml/min/1.73 m(2)) were evaluated for cognitive dysfunction using the validated Standardized Mini-Mental State Examination (SMMSE). Individuals with dementia, depression or other psychiatric disorders were excluded, as were subjects on uric acid-lowering therapy or with serious illnesses such as severe anemia or active or ongoing cardiovascular or cerebrovascular disease. RESULTS: 247 subjects were enrolled. SMMSE scores showed stepwise deterioration with increasing quartile of serum uric acid (26.4; 26.1; 25.5; 25.3, score range 20-30, p = 0.019). Post-hoc analysis demonstrated that there was no linear trend and only groups 1 and 4 were different with respect to SMMSE scores (p = 0.025). Stepwise multivariate linear regression revealed that age, educational status, presence of cerebrovascular disease, and serum uric acid were independently related to SMMSE scores. CONCLUSION: Serum uric acid levels are independently and inversely associated with mild cognitive dysfunction in subjects with CKD.
Authors: Antonio Cherubini; David T Lowenthal; Esther Paran; Patrizia Mecocci; Leonard S Williams; Umberto Senin Journal: Dis Mon Date: 2010-03 Impact factor: 3.800
Authors: Richard J Johnson; Mark S Segal; Titte Srinivas; Ahsan Ejaz; Wei Mu; Carlos Roncal; Laura G Sánchez-Lozada; Michael Gersch; Bernardo Rodriguez-Iturbe; Duk-Hee Kang; Jaime Herrera Acosta Journal: J Am Soc Nephrol Date: 2005-04-20 Impact factor: 10.121
Authors: Nurcan Basar; Nihat Sen; Firat Ozcan; Gonul Erden; Selcuk Kanat; Erdogan Sokmen; Ahmet Isleyen; Huseyin Yuzgecer; Mehmet Fatih Ozlu; Metin Yildirimkaya; Orhan Maden; Adrian Covic; Richard J Johnson; Mehmet Kanbay Journal: J Investig Med Date: 2011-08 Impact factor: 2.895
Authors: D J Schretlen; A B Inscore; T D Vannorsdall; M Kraut; G D Pearlson; B Gordon; H A Jinnah Journal: Neurology Date: 2007-10-02 Impact factor: 9.910
Authors: Michael C Irizarry; Rema Raman; Michael A Schwarzschild; Lida M Becerra; Ronald G Thomas; Ronald C Peterson; Alberto Ascherio; Paul S Aisen Journal: Neurodegener Dis Date: 2008-11-05 Impact factor: 2.977
Authors: Mary Hannan; Alana Steffen; Lauretta Quinn; Eileen G Collins; Shane A Phillips; Ulf G Bronas Journal: J Nephrol Date: 2018-05-25 Impact factor: 3.902
Authors: May A Beydoun; Jose-Atilio Canas; Gregory A Dore; Hind A Beydoun; Ola S Rostant; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman Journal: J Alzheimers Dis Date: 2016-04-21 Impact factor: 4.472